Related Experiment Video
Updated: Jul 22, 2025
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
Loss of TSC1 in secondary angiosarcoma of the breast
Lucy Rose1, Nicci Owusu-Brackett1, Stephen Moore2
1Division of Surgical Oncology, Department of Surgery The Ohio State University Wexner Medical Center Columbus Ohio USA.
Key Clinical Message:
Post-radiation angiosarcoma of the breast is a rare complication associated with a poor prognosis. This case reports the first loss of function mutation in TSC1 in breast radiation-induced angiosarcoma and illustrates the utility of evaluating these markers to identify potential therapeutic targets.
Abstract:
Post-radiation angiosarcoma of the breast is rare and associated with a poor prognosis. This case presents the first loss of function mutation in TSC1 in breast radiation-induced angiosarcoma. Evaluation of these markers can aid in identifying potential therapeutic targets.
Insights
Radiation-induced angiosarcoma of the breast is rare and has a poor prognosis. This case study identifies the first loss of function mutation in TSC1, highlighting its potential as a therapeutic target for this rare cancer.
Area of Science:
- Oncology
- Genetics
- Radiation Oncology
Background:
- Post-radiation angiosarcoma of the breast is a rare but aggressive complication.
- This condition is associated with a poor prognosis and limited therapeutic options.
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...